EBV-encoded LMP1 upregulates Igκ 3'enhancer activity and Igκ expression in nasopharyngeal cancer cells by activating the Ets-1 through ERKs signaling.

Abstract

Accumulating evidence indicates that epithelial cancer cells, including nasopharyngeal carcinoma (NPC) cells, express immunoglobulins (Igs). We previously found that the expression of the kappa light chain protein in NPC cells can be upregulated by the EBV-encoded latent membrane protein 1 (LMP1). In the present study, we used NPC cell lines as models and found that LMP1-augmented kappa production corresponds with elevations in ERKs phosphorylation. PD98059 attenuates LMP1-induced ERKs phosphorylation resulting in decreased expression of the kappa light chain. ERK-specific small interfering RNA blunts LMP1-induced kappa light chain gene expression. Luciferase reporter assays demonstrate that immunoglobulin κ 3' enhancer (3'E(κ)) is active in Igκ-expressing NPC cells and LMP1 upregulates the activity of 3'E(κ) in NPC cells. Moreover, mutation analysis of the PU binding site in 3'E(κ) and inhibition of the MEK/ERKs pathway by PD98059 indicate that the PU site is functional and LMP1-enhanced 3'E(κ) activity is partly regulated by this site. PD98059 treatment also leads to a concentration-dependent inhibition of LMP1-induced Ets-1 expression and phosphorylation, which corresponds with a dose-dependent attenuation of LMP1-induced ERK phosphorylation and kappa light chain expression. Suppression of endogenous Ets-1 by small interfering RNA is accompanied by a decrease of Ig kappa light chain expression. Gel shift assays using nuclear extracts of NPC cells indicate that the transcription factor Ets-1 is recruited by LMP1 to the PU motif within 3'E(κ)in vitro. ChIP assays further demonstrate Ets-1 binding to the PU motif of 3'E(κ) in cells. These results suggest that LMP1 upregulates 3'E(κ) activity and kappa gene expression by activating the Ets-1 transcription factor through the ERKs signaling pathway. Our studies provide evidence for a novel regulatory mechanism of kappa expression, by which virus-encoded proteins activate the kappa 3' enhancer through activating transcription factors in non-B epithelial cancer cells.

• Authors: Haidan Liu, Zhi Duan, Hui Zheng, Duosha Hu, Ming Li, Yongguang Tao, Ann M Bode, Zigang Dong, Ya Cao
• Journal: PloS one (PLoS One) Vol. 7 Issue 3 Pg. e32624 ( 2012) ISSN: 1932-6203 [Electronic] United States
• PMID: 22396784 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• EBV-associated membrane antigen, Epstein-Barr virus
• ETS1 protein, human
• Enzyme Inhibitors
• Flavonoids
• IgK
• Immunoglobulins
• Oligonucleotides
• Proto-Oncogene Protein c-ets-1
• RNA, Small Interfering
• Viral Matrix Proteins
• Extracellular Signal-Regulated MAP Kinases
• 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one

Topics

• Binding Sites
• Carcinoma
• Cell Line, Tumor
• DNA Mutational Analysis
• Enzyme Inhibitors (pharmacology)
• Extracellular Signal-Regulated MAP Kinases (metabolism)
• Flavonoids (pharmacology)
• Gene Expression Regulation, Neoplastic
• Gene Expression Regulation, Viral
• Herpesvirus 4, Human (metabolism)
• Humans
• Immunoglobulins (metabolism)
• Nasopharyngeal Carcinoma
• Nasopharyngeal Neoplasms (metabolism)
• Oligonucleotides (genetics)
• Phosphorylation
• Proto-Oncogene Protein c-ets-1 (metabolism)
• RNA Interference
• RNA, Small Interfering (metabolism)
• Signal Transduction
• Viral Matrix Proteins (metabolism)